Skip to main content

GMP

GMP Training: Good Manufacturing Practice for Pharmaceutical Professionals

Good Manufacturing Practice is the body of requirements ensuring that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use. It is not a checklist; it is a philosophy of control that assumes quality cannot be tested into a product after the fact and must instead be built into every step of its manufacture.

This GMP training resource covers the principles that every pharmaceutical professional is expected to understand — regardless of function — together with the ICH framework, the documentation and contamination control disciplines, and the expectations that regulatory inspectors apply on the shop floor.

  • The ten core principles of cGMP
  • ICH Q7, Q8, Q9 and Q10 and how they connect
  • Documentation, contamination control and qualification
  • What inspectors actually look for during a GMP audit

The core principles of cGMP

The letter 'c' in cGMP stands for current, and it carries real weight. A control strategy that was acceptable a decade ago may no longer be defensible, because the expectation moves with available technology and accumulated regulatory experience. Sites that treat GMP as a fixed standard rather than a moving one accumulate observations.

Across every regional GMP code — 21 CFR Parts 210 and 211, EU GMP, Schedule M and the WHO guidance — the same underlying principles recur.

  • Define, validate and control all manufacturing processes
  • Control and monitor critical process parameters and quality attributes
  • Write clear, unambiguous instructions and keep them current
  • Train operators to perform procedures competently and record that training
  • Record every action contemporaneously and legibly at the time it is performed
  • Investigate all deviations and record their outcome and impact
  • Retain records in a retrievable form for the required retention period
  • Design facilities, utilities and equipment to prevent contamination and mix-ups
  • Establish a recall system capable of retrieving any batch from the market
  • Handle complaints, examine causes and take action to prevent recurrence

The ICH quality framework

Four ICH guidelines form the modern quality architecture. ICH Q7 sets GMP requirements for active pharmaceutical ingredients. ICH Q8 introduces pharmaceutical development and Quality by Design, including the design space concept. ICH Q9 establishes quality risk management as a formal discipline with defined tools. ICH Q10 describes the pharmaceutical quality system that ties development, manufacture and continual improvement together.

Read together, they describe a coherent intent: understand your product and process scientifically, manage risk explicitly and proportionately, and operate a quality system that detects and corrects drift before it becomes failure.

Practically, this means risk assessments should drive decisions rather than justify them retrospectively, and process understanding should be documented in a form that supports change without repeating full validation each time.

Documentation and the batch record

In a GMP environment, the record is the evidence. The batch manufacturing record is the single most examined document in any inspection, because it demonstrates whether the approved process was actually followed on a specific day by specific people using specific equipment and materials.

Good documentation practice is therefore a technical skill, not clerical work. Entries must be contemporaneous, made in indelible ink, legible, attributable to an identified individual, and corrected by a single line strike-through with initials, date and reason — never obscured, overwritten or erased. Blank fields must be addressed rather than left empty.

Electronic batch records shift but do not remove these obligations. Access control, audit trail review, validated calculations, and controlled handling of exceptions become the equivalent disciplines.

Contamination control and facility design

Contamination control begins with facility layout — unidirectional flows of personnel, materials and waste; appropriate pressure differentials between classified areas; airlocks; and physical segregation of incompatible operations such as beta-lactam and non-beta-lactam manufacture.

Cleaning validation demonstrates that residues from a previous product, cleaning agents and microbial load are reduced to scientifically justified acceptance limits, typically based on health-based exposure limits. Sampling must cover worst-case locations, and analytical methods must be validated for the specific residues at the required sensitivity.

For sterile products, the revised EU GMP Annex 1 has substantially raised expectations around contamination control strategy, aseptic process simulation, barrier technology and environmental monitoring — and its influence extends well beyond Europe.

Qualification and validation

Qualification establishes that facilities, utilities and equipment are suitable and function correctly; validation establishes that processes, cleaning procedures and analytical methods consistently deliver the intended result. The two are linked through the validation master plan, which defines scope, approach, responsibilities and acceptance criteria for the site.

Equipment qualification follows the familiar sequence of design, installation, operational and performance qualification. Process validation now follows a lifecycle model — process design, process qualification, and continued process verification — replacing the older idea that three successful batches conclude the exercise.

Computerised system validation deserves particular attention because it is where GMP and data integrity intersect. Systems must be validated for intended use, with documented user requirements, risk-based testing, controlled access, secure audit trails and defined data backup and archival.

GMP inspection readiness

Inspectors form a judgement about a site remarkably quickly, and much of that judgement comes from the shop floor rather than the document room. Clean and current logbooks, correctly labelled equipment status, operators who can explain what they are doing and why, and investigations that are progressing on schedule all signal a controlled system.

The reverse signals are equally quick to read — uncontrolled loose paper, overdue CAPAs, training records that lag procedure revisions, and equipment status labels that contradict the logbook.

Effective GMP training programmes therefore target behaviour, not memorisation. Role-based curricula, on-the-job qualification, and periodic refreshers tied to procedure revisions produce a workforce that behaves correctly under normal pressure rather than one that recites definitions during an audit.

Frequently asked questions

What is GMP in the pharmaceutical industry?

Good Manufacturing Practice is the set of regulatory requirements ensuring that medicinal products are consistently produced and controlled to quality standards appropriate to their intended use. It covers premises, equipment, personnel, documentation, production, quality control, complaints and recalls, and it requires that quality be built into the process rather than tested into the product afterwards.

What is the difference between GMP and cGMP?

They describe the same body of requirements, but the 'c' in cGMP emphasises 'current' — the expectation that manufacturers use up-to-date technologies, systems and control strategies rather than relying on approaches that were acceptable in the past.

What is the difference between GMP and GLP?

GMP governs the manufacture of medicinal products for commercial supply. Good Laboratory Practice governs the conduct of non-clinical safety studies, focusing on study planning, conduct, monitoring, recording, archiving and reporting so that regulatory authorities can rely on the data submitted.

Which ICH guidelines are most important for GMP?

ICH Q7 covers GMP for active pharmaceutical ingredients, Q8 covers pharmaceutical development and Quality by Design, Q9 covers quality risk management, and Q10 describes the pharmaceutical quality system. Together they define the modern expectation of science and risk-based manufacturing control.

How often should GMP training be repeated?

Induction training is required before independent work, role-based training must be completed whenever responsibilities change, and refresher training is typically conducted annually. In addition, any revision to a procedure triggers retraining for every affected individual before the revised procedure takes effect.

Reinforce your GMP knowledge

Practise GMP, data integrity and manufacturing MCQs written around real inspection scenarios.